Drug Approval | June 13, 2026
UK approves Wegovy pill in major shift in obesity treatment options
Approval is based on results from the phase 3 OASIS 4 clinical trial
Approval is based on results from the phase 3 OASIS 4 clinical trial
MeRT becomes one of the few FDA-cleared neuromodulation therapies for PTSD, using EEG biomarkers and AI to personalize treatment for patients with treatment-resistant symptoms
Dr. Quirk said the program’s mechanism offers a targeted approach to disrupted brain signaling in compulsivity-related disorders
Two-year collaboration aims to strengthen primary healthcare systems, generate real-world evidence, and support responsible adoption of AI and digital health technologies across South-East Asia
Knowledge paper highlights biosimilars, biologics, AI-driven drug discovery and regulatory excellence as key growth drivers for the next phase of India's pharma expansion
Orbis India Country Director recognized by the Lions Council of India for efforts to expand access to quality eye care among underserved communities.
SENS study to assess feasibility, effectiveness and family experience of introducing SMA screening into the NHS newborn screening programme
KIHT can now conduct clinical research for drugs and medical devices, strengthening evidence generation and healthcare innovation
Union Minister inaugurated a DST-funded Central Instrumentation Facility and three new research clusters focused on advanced materials, clean energy, and healthcare at IIT Gandhinagar
The film tells the story of a 70-year-old woman from Kota, Rajasthan, whose persistent cough led to a diagnosis of advanced lung cancer
Subscribe To Our Newsletter & Stay Updated
